Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure

Leejane Lu, Shen Nan Lin, James J. Grady, Manubai Nagamani, Karl Anderson

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Soybean consumption may be protective for breast cancer, possibly due in part to the presence of the isoflavones daidzein and genistein, which are weakly estrogenic. The metabolism and disposition of these phytoestrogens during chronic soya exposure were studied on a metabolic unit. Six healthy 22- to 29-year-old women consumed an unrestricted hospital diet for most of the study and ingested 12 oz of soymilk with each meal for one month. At two- week intervals, excretion of isoflavones in urine was studied, during which time the subjects consumed a constant basal diet for three to four days, ingested the full daily 36-oz portion of soymilk within 30 minutes each day for one to two days, and collected urine continuously. Urinary recovery of genistein [initially 23.9 + 17.3% (SD) of ingested genistin + genistein], daidzein (initially 66.2 ± 23.5% of ingested daidzin + daidzein), and equol (initially 28% of the ingested precursors daidzin + daidzein in 1 subject and <1% in 5 subjects) decreased progressively over four weeks of daily soya ingestion by 42% for genistein (p < 0.05) and 31% for daidzein (p < 0.01) but increased by 3- to 100-fold for equol (4 subjects, p < 0.05). Total amounts excreted and peak levels were similarly affected. The absorption half-lives (t(1/2)) for genistein and daidzein were initially 2.7 ± 0.8 and 1.6 ± 0.5 hours, respectively, and during four weeks of soymilk ingestion decreased to 2.0 ± 0.6 (p = 0.04) and 1.4 ± 0.2 hours (p = 0.06), respectively, suggesting more rapid absorption. The appearance t(1/2) of equol can be estimated for only one subject initially (2.9 hrs), but during four weeks of soya ingestion it could be estimated for three more subjects (4.7 ± 2.3 hrs). The excretion t(1/2) values for genistein and daidzein were initially 6.7 ± 0.8 and 4.4 ± 0.7 hours, respectively, and during four weeks of soymilk ingestion decreased to 4.2 ± 1.2 (p = 0.005) and 3.2 ± 1.1 hours (p = 0.005), respectively, suggesting more rapid excretion. For equol, the excretion t(1/2) was initially 9.1 hours (1 subject), and after two and four weeks of soymilk ingestion it was 13.4 ± 9.7 and 5.5 ± 1.6 hours (4 subjects, p = 0.046, 2 wks vs. 4 wks), respectively. These results indicate that metabolism and disposition of ingested isoflavones are altered during chronic soya ingestion in women, perhaps from increased metabolic degradation to formation of nonisoflavone metabolites. Increased production of the longer- and stronger-acting estrogenic equol in some women during chronic soymilk ingestion may alter the estrogenic potency of dietary soya isoflavones.

Original languageEnglish (US)
Pages (from-to)289-302
Number of pages14
JournalNutrition and Cancer
Volume26
Issue number3
StatePublished - 1996

Fingerprint

daidzein
Genistein
genistein
Equol
soymilk
excretion
Eating
ingestion
Isoflavones
kinetics
isoflavones
daidzin
urine
hospital diet
Urine
Diet
genistin
Phytoestrogens
plant estrogens
metabolism

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Food Science

Cite this

Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure. / Lu, Leejane; Lin, Shen Nan; Grady, James J.; Nagamani, Manubai; Anderson, Karl.

In: Nutrition and Cancer, Vol. 26, No. 3, 1996, p. 289-302.

Research output: Contribution to journalArticle

@article{48f7aaacb54040b6b186bf1311969c3b,
title = "Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure",
abstract = "Soybean consumption may be protective for breast cancer, possibly due in part to the presence of the isoflavones daidzein and genistein, which are weakly estrogenic. The metabolism and disposition of these phytoestrogens during chronic soya exposure were studied on a metabolic unit. Six healthy 22- to 29-year-old women consumed an unrestricted hospital diet for most of the study and ingested 12 oz of soymilk with each meal for one month. At two- week intervals, excretion of isoflavones in urine was studied, during which time the subjects consumed a constant basal diet for three to four days, ingested the full daily 36-oz portion of soymilk within 30 minutes each day for one to two days, and collected urine continuously. Urinary recovery of genistein [initially 23.9 + 17.3{\%} (SD) of ingested genistin + genistein], daidzein (initially 66.2 ± 23.5{\%} of ingested daidzin + daidzein), and equol (initially 28{\%} of the ingested precursors daidzin + daidzein in 1 subject and <1{\%} in 5 subjects) decreased progressively over four weeks of daily soya ingestion by 42{\%} for genistein (p < 0.05) and 31{\%} for daidzein (p < 0.01) but increased by 3- to 100-fold for equol (4 subjects, p < 0.05). Total amounts excreted and peak levels were similarly affected. The absorption half-lives (t(1/2)) for genistein and daidzein were initially 2.7 ± 0.8 and 1.6 ± 0.5 hours, respectively, and during four weeks of soymilk ingestion decreased to 2.0 ± 0.6 (p = 0.04) and 1.4 ± 0.2 hours (p = 0.06), respectively, suggesting more rapid absorption. The appearance t(1/2) of equol can be estimated for only one subject initially (2.9 hrs), but during four weeks of soya ingestion it could be estimated for three more subjects (4.7 ± 2.3 hrs). The excretion t(1/2) values for genistein and daidzein were initially 6.7 ± 0.8 and 4.4 ± 0.7 hours, respectively, and during four weeks of soymilk ingestion decreased to 4.2 ± 1.2 (p = 0.005) and 3.2 ± 1.1 hours (p = 0.005), respectively, suggesting more rapid excretion. For equol, the excretion t(1/2) was initially 9.1 hours (1 subject), and after two and four weeks of soymilk ingestion it was 13.4 ± 9.7 and 5.5 ± 1.6 hours (4 subjects, p = 0.046, 2 wks vs. 4 wks), respectively. These results indicate that metabolism and disposition of ingested isoflavones are altered during chronic soya ingestion in women, perhaps from increased metabolic degradation to formation of nonisoflavone metabolites. Increased production of the longer- and stronger-acting estrogenic equol in some women during chronic soymilk ingestion may alter the estrogenic potency of dietary soya isoflavones.",
author = "Leejane Lu and Lin, {Shen Nan} and Grady, {James J.} and Manubai Nagamani and Karl Anderson",
year = "1996",
language = "English (US)",
volume = "26",
pages = "289--302",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "3",

}

TY - JOUR

T1 - Altered kinetics and extent of urinary daidzein and genistein excretion in women during chronic soya exposure

AU - Lu, Leejane

AU - Lin, Shen Nan

AU - Grady, James J.

AU - Nagamani, Manubai

AU - Anderson, Karl

PY - 1996

Y1 - 1996

N2 - Soybean consumption may be protective for breast cancer, possibly due in part to the presence of the isoflavones daidzein and genistein, which are weakly estrogenic. The metabolism and disposition of these phytoestrogens during chronic soya exposure were studied on a metabolic unit. Six healthy 22- to 29-year-old women consumed an unrestricted hospital diet for most of the study and ingested 12 oz of soymilk with each meal for one month. At two- week intervals, excretion of isoflavones in urine was studied, during which time the subjects consumed a constant basal diet for three to four days, ingested the full daily 36-oz portion of soymilk within 30 minutes each day for one to two days, and collected urine continuously. Urinary recovery of genistein [initially 23.9 + 17.3% (SD) of ingested genistin + genistein], daidzein (initially 66.2 ± 23.5% of ingested daidzin + daidzein), and equol (initially 28% of the ingested precursors daidzin + daidzein in 1 subject and <1% in 5 subjects) decreased progressively over four weeks of daily soya ingestion by 42% for genistein (p < 0.05) and 31% for daidzein (p < 0.01) but increased by 3- to 100-fold for equol (4 subjects, p < 0.05). Total amounts excreted and peak levels were similarly affected. The absorption half-lives (t(1/2)) for genistein and daidzein were initially 2.7 ± 0.8 and 1.6 ± 0.5 hours, respectively, and during four weeks of soymilk ingestion decreased to 2.0 ± 0.6 (p = 0.04) and 1.4 ± 0.2 hours (p = 0.06), respectively, suggesting more rapid absorption. The appearance t(1/2) of equol can be estimated for only one subject initially (2.9 hrs), but during four weeks of soya ingestion it could be estimated for three more subjects (4.7 ± 2.3 hrs). The excretion t(1/2) values for genistein and daidzein were initially 6.7 ± 0.8 and 4.4 ± 0.7 hours, respectively, and during four weeks of soymilk ingestion decreased to 4.2 ± 1.2 (p = 0.005) and 3.2 ± 1.1 hours (p = 0.005), respectively, suggesting more rapid excretion. For equol, the excretion t(1/2) was initially 9.1 hours (1 subject), and after two and four weeks of soymilk ingestion it was 13.4 ± 9.7 and 5.5 ± 1.6 hours (4 subjects, p = 0.046, 2 wks vs. 4 wks), respectively. These results indicate that metabolism and disposition of ingested isoflavones are altered during chronic soya ingestion in women, perhaps from increased metabolic degradation to formation of nonisoflavone metabolites. Increased production of the longer- and stronger-acting estrogenic equol in some women during chronic soymilk ingestion may alter the estrogenic potency of dietary soya isoflavones.

AB - Soybean consumption may be protective for breast cancer, possibly due in part to the presence of the isoflavones daidzein and genistein, which are weakly estrogenic. The metabolism and disposition of these phytoestrogens during chronic soya exposure were studied on a metabolic unit. Six healthy 22- to 29-year-old women consumed an unrestricted hospital diet for most of the study and ingested 12 oz of soymilk with each meal for one month. At two- week intervals, excretion of isoflavones in urine was studied, during which time the subjects consumed a constant basal diet for three to four days, ingested the full daily 36-oz portion of soymilk within 30 minutes each day for one to two days, and collected urine continuously. Urinary recovery of genistein [initially 23.9 + 17.3% (SD) of ingested genistin + genistein], daidzein (initially 66.2 ± 23.5% of ingested daidzin + daidzein), and equol (initially 28% of the ingested precursors daidzin + daidzein in 1 subject and <1% in 5 subjects) decreased progressively over four weeks of daily soya ingestion by 42% for genistein (p < 0.05) and 31% for daidzein (p < 0.01) but increased by 3- to 100-fold for equol (4 subjects, p < 0.05). Total amounts excreted and peak levels were similarly affected. The absorption half-lives (t(1/2)) for genistein and daidzein were initially 2.7 ± 0.8 and 1.6 ± 0.5 hours, respectively, and during four weeks of soymilk ingestion decreased to 2.0 ± 0.6 (p = 0.04) and 1.4 ± 0.2 hours (p = 0.06), respectively, suggesting more rapid absorption. The appearance t(1/2) of equol can be estimated for only one subject initially (2.9 hrs), but during four weeks of soya ingestion it could be estimated for three more subjects (4.7 ± 2.3 hrs). The excretion t(1/2) values for genistein and daidzein were initially 6.7 ± 0.8 and 4.4 ± 0.7 hours, respectively, and during four weeks of soymilk ingestion decreased to 4.2 ± 1.2 (p = 0.005) and 3.2 ± 1.1 hours (p = 0.005), respectively, suggesting more rapid excretion. For equol, the excretion t(1/2) was initially 9.1 hours (1 subject), and after two and four weeks of soymilk ingestion it was 13.4 ± 9.7 and 5.5 ± 1.6 hours (4 subjects, p = 0.046, 2 wks vs. 4 wks), respectively. These results indicate that metabolism and disposition of ingested isoflavones are altered during chronic soya ingestion in women, perhaps from increased metabolic degradation to formation of nonisoflavone metabolites. Increased production of the longer- and stronger-acting estrogenic equol in some women during chronic soymilk ingestion may alter the estrogenic potency of dietary soya isoflavones.

UR - http://www.scopus.com/inward/record.url?scp=0029808513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029808513&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 289

EP - 302

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 3

ER -